Michael Finney

Vaxart, Inc. develops technology for oral vaccination against infectious agents. Its products in pipeline include H1N1 seasonal influenza vaccine and oral H5N1 avian influenza vaccine. The firm develops oral recombinant vaccines based on its proprietary oral vaccine delivery platform. The company was founded by Sean N. Tucker in 2004 and is headquartered in San Francisco, CA.

Banyan Energy, Inc. develops solar technology. Its technologies are based on aggregated total internal reflection, through which the light is concentrated, aggregated and delivered to a focal area via a waveguide. The firm offers its products for deployment in the solar industry. The company was founded by Shondip Ghosh, Matthew Evans and David Schultz in August 2007 and is headquartered in Fremont, CA.

Innerscope Research, Inc. operates as a media research firm. It specializes in marketing, biometrics, research, biometric research, market research, neuromarketing, neuroscience, facial coding, consumer neuroscience, eye tracking, implicit testing and media research. The company was founded by Carl D. Marci in 2006 and is headquartered in Newton, MA.

PharmaSecure, Inc. provides anti-counterfeiting solutions for emerging markets. It protects patients from the threat of counterfeit medicines. The firm offers its brand protection platform to a wide-range of industries including FMCG, beauty and personal care, electronics, automotive, and agri-business. The company was founded by Taylor N. Thompson, Sarah Hine and Nathan J. Sigworth in November 2007 and is headquartered in New York, NY.

Nanotech Biomachines, Inc. produces industrial-grade grapheme. It offers are used for computer transistors, radio-frequency transistors for cell phones, batteries, solar cells, printable electronics and touch displays. The company was by founded by Will Martinez and is headquartered in Berkeley, CA.

Essen Instruments, Inc. engages in the development and manufacture of cell and bead based screening solutions. It offers phenotypic drug discovery, antibody discovery and in vitro toxicity testing. The firm’s proprietary technologies, instrumentation, assays and software products address the pervasive need to provide turnkey solutions that increase productivity in pharmaceutical, biotechnology and life science research. The company’s products are used in biologics discovery, small molecules, in vitro tox and cellular research antibody applications. The company was founded by R. Terry Dunlay, Larry A. Sklar, and Bruce S. Edwards in 2006 and is headquartered in Ann Arbor, MI.

Finney Capital (Finney Capital) is a venture capital firm founded in 2004. The firm is headquartered in San Francisco, California.